DANBURY, CT, April 24, 2012 – IMS Health has acquired DecisionView, a San Francisco-based software solutions company that helps life sciences organizations plan and track patient enrollment for ...

Pursuing claims-based data on what happens to patients taking their drugs, pharma companies have been striking pacts with payers and PBMs. Now, a heavyweight in the research field, IMS Health, has ...

IMS Health has acquired TTC, a Philadelphia-based benchmarking solutions and analytics company that helps life sciences organizations around the world plan for and negotiate the costs of clinical ...

DANBURY, Conn.--(BUSINESS WIRE)--IMS Health (NYSE:IMS) has acquired Dataline Software, a leader in Big Data analytics for healthcare, to extend its technology-enabled Real-World Evidence (RWE) ...

Last year, the US pharmaceuticals market grew at its slowest rate since 1961, research firm IMS Health said today. According to the results of IMS’ US Pharmaceutical Market Performance Review, sales ...

NORWALK, Conn. The size of the global pharmaceutical market will hit the $1 trillion mark by 2014, according to a new report by market research firm IMS Health. IMS said the market was expected to ...

PARSIPPANY, NJ, May 9, 2013 – Total spending on U.S. medicines fell 3.5 percent on a real per capita basis in 2012 and the use of healthcare services overall declined for the second consecutive year, ...

NORWALK, Conn. Strong near-term growth in the U.S. pharmaceutical market will drive growth in the global pharmaceutical market, according to a forecast by market research firm IMS Health. In its IMS ...